{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:45:23Z","timestamp":1761659123102,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ajg.2019.11.003","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T17:38:40Z","timestamp":1575308320000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Mona Zaky","family":"Nasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa Ali","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Mahmoud","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Khairy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajg.2019.11.003_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.13186","article-title":"The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment","volume":"37","author":"Kandeel","year":"2017","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.ajg.2019.11.003_b0010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/jmv.20679","article-title":"HCV-related morbidity in a rural community of Egypt","volume":"78","author":"Mohamed","year":"2006","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.ajg.2019.11.003_b0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2893.2012.01650.x","article-title":"Towards realistic estimates of HCV incidence in Egypt","volume":"20","author":"Breban","year":"2013","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.ajg.2019.11.003_b0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajg.2019.11.003_b0025","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7314\/APJCP.2015.16.3.1281","article-title":"Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in Egyptian patients","volume":"16","author":"Zekri","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"10.1016\/j.ajg.2019.11.003_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137706","article-title":"Serum microRNAs as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma in Egyptian patients","volume":"10","author":"Motawi","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajg.2019.11.003_b0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hep.26095","article-title":"MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?","volume":"57","author":"Giordano","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ajg.2019.11.003_b0040","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.cellsig.2012.07.023","article-title":"The potential of microRNAs in liver fibrosis","volume":"24","author":"He","year":"2012","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.ajg.2019.11.003_b0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gendis.2015.01.001","article-title":"MicroRNAs: role in hepatitis C virus pathogenesis","volume":"2","author":"Shrivastava","year":"2015","journal-title":"Genes Dis"},{"key":"10.1016\/j.ajg.2019.11.003_b0050","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/hep.22158","article-title":"MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma","volume":"47","author":"Varnholt","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2019.11.003_b0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.ajg.2019.11.003_b0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ajg.2019.11.003_b0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajg.2019.11.003_b0070","first-page":"39","article-title":"Hepatic diseases related peripheral blood RNAs variation and their clinical significance","volume":"3","author":"Tian","year":"2012","journal-title":"J Mol Biomark Diagn"},{"issue":"5","key":"10.1016\/j.ajg.2019.11.003_b0075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/bab.1767","volume":"66","author":"Zou","year":"2019","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.ajg.2019.11.003_b0080","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"46","key":"10.1016\/j.ajg.2019.11.003_b0085","doi-asserted-by":"crossref","first-page":"75038","DOI":"10.18632\/oncotarget.12602","article-title":"miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt\/\u03b2-catenin signaling pathway","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ajg.2019.11.003_b0090","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1007\/s13277-016-5097-8","article-title":"Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection","volume":"37","author":"Zekri","year":"2016","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.ajg.2019.11.003_b0095","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/cdd.2010.164","article-title":"MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival","volume":"18","author":"Afanasyeva","year":"2011","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.ajg.2019.11.003_b0100","doi-asserted-by":"crossref","first-page":"38262","DOI":"10.1038\/srep38262","article-title":"Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study","volume":"5","author":"Raitoharju","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajg.2019.11.003_b0105","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hep.22160","article-title":"Identification of metastasis-related microRNAs in hepatocellular carcinoma","volume":"47","author":"Budhu","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2019.11.003_b0110","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","author":"Murakami","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ajg.2019.11.003_b0115","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajg.2019.11.003_b0120","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajg.2019.11.003_b0125","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","article-title":"miR-21-mediated tumor growth","volume":"26","author":"Si","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ajg.2019.11.003_b0130","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"MicroRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajg.2019.11.003_b0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/107327480501200407","article-title":"Enhanced detection of hepatocellular carcinoma","volume":"4","author":"ElHouseini","year":"2005","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.ajg.2019.11.003_b0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2010.02.021","article-title":"MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma","volume":"53","author":"Liu","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2019.11.003_b0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2011.04.026","article-title":"Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma","volume":"56","author":"Tomimaru","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2019.11.003_b0150","article-title":"Circulating MiRNA-21 and programed cell death (PDCD) 4 gene expression in hepatocellular carcinoma (HCC) in Egyptian patients","author":"ElGedawy","year":"2016","journal-title":"Egypt J Med Hum Genet"},{"issue":"09","key":"10.1016\/j.ajg.2019.11.003_b0155","first-page":"052","article-title":"Expression of microRNAs-21 and-223 in hepatocellular carcinoma in hepatitis C virus infected Egyptian population","volume":"7","author":"Elghoroury","year":"2017","journal-title":"J Appl Pharm Sci"},{"key":"10.1016\/j.ajg.2019.11.003_b0160","doi-asserted-by":"crossref","first-page":"1806069","DOI":"10.1155\/2017\/1806069","article-title":"Detection of microRNA in hepatic cirrhosis and hepatocellular carcinoma in hepatitis C genotype-4 in Egyptian patients","volume":"2017","author":"Demerdash","year":"2017","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.ajg.2019.11.003_b0165","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/hep.22256","article-title":"MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene\/tumor suppressor gene mutations","volume":"47","author":"Ladeiro","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2019.11.003_b0170","doi-asserted-by":"crossref","first-page":"11573","DOI":"10.4238\/2015.September.28.9","article-title":"Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis","volume":"14","author":"Yan","year":"2015","journal-title":"Genet Mol Res"},{"issue":"3","key":"10.1016\/j.ajg.2019.11.003_b0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","article-title":"MicroRNAs in NF-kappaB signaling","volume":"3","author":"Ma","year":"2011","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.ajg.2019.11.003_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039520","article-title":"Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancerstem cell phenotype through AKT\/ERK1\/2 inactivation by targeting PTEN","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ajg.2019.11.003_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026971","article-title":"Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma","volume":"6","author":"Bihrer","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ajg.2019.11.003_b0190","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-008-0629-8","article-title":"Association of MicroRNA-223 expression with hepatic ischemia\/reperfusion injury in mice","volume":"54","author":"Yu","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.ajg.2019.11.003_b0195","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/jvh.12696","article-title":"Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients","volume":"24","author":"Shaker","year":"2017","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.ajg.2019.11.003_b0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2008.04.003","article-title":"MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1","volume":"135","author":"Wong","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ajg.2019.11.003_b0205","first-page":"2699","article-title":"Serum miRNA panel in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma","volume":"17","author":"Khairy","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ajg.2019.11.003_b0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4149\/neo_2013_018","article-title":"Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma","volume":"60","author":"Qi","year":"2013","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.ajg.2019.11.003_b0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mc.20712","article-title":"Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis","volume":"50","author":"Xu","year":"2011","journal-title":"Mol Carcinog"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719791930098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719791930098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:40:53Z","timestamp":1761658853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168719791930098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S168719791930098X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2019.11.003","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2019.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of Pan-Arab Association of Gastroenterology.","name":"copyright","label":"Copyright"}]}}